<!DOCTYPE html><html lang="spanish" >

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.8.0">

  

  
  
  
  
  
    
    
      
    
    
  
  

  

  
  
  
    
  
  <meta name="description" content="Background: Models for liver transplant (LT) allocation have been trained to predict mortality or delisting for sickness at 90 days. Their performance in a context of waiting list shortening is uncertain. Methods: Retrospective study of two cohorts of patients enlisted for LT in the UK (2010-2020) and Australia (1997-2020). Mortality or delisting for sickness within the first 30 and 60 days was evaluated. Harrell’s c statistics (Hc) were used to assess discrimination. Results: In all, 7,133 patients from the UK (33% women) and 1,638 patients from Australia (26.4% women) were included. Mortality or delisting for sickness at 30 and 60 days were 2.6% and 4.5% in the UK, and 2.7% and 4.6% in Australia. In the UK at 30 days, GEMA-Na obtained the highest discrimination (Hc=0.818; 95%CI 0.783-0.853), followed by MELD-Na (Hc=0.796; 95%CI 0.759-0.834; p=0.004), and MELD 3.0 (Hc=0.782; 95%CI 0.743-0.821; p&lt;0.001). In Australia at 30 days, the most accurate forecasts came from GEMA-Na (Hc=0.832; 95%CI 0.770-0.894), followed by MELD 3.0 (Hc=0.805; 95%CI 0.737-0.872; p=0.030), and MELD-Na (Hc=0.789; 95%CI 0.717-0.861; p=0.018). The discrimination benefit of GEMA-Na at 30 days was more pronounced in women: Hc=0.824 (95%CI 0.767-0.822) in the UK, and Hc=0.856 (95%CI 0.768-0.944) in Australia. Results were similar at 60 days. Differential prioritization at 30 days occurred in 15% of patients when comparing GEMA-Na vs MELD-Na, and in 15.3% of patients when comparing GEMA-Na vs MELD 3.0. Patients differently prioritized by GEMA-Na over MELD-Na had higher risk of the outcome at 30 days (OR=2.5; p=0.043) and at 60 days (OR=4.2; p=0.005). Patients differently prioritized by GEMA-Na over MELD 3.0 had increased likelihood of the outcome at 30 days (OR=7.3; p=0.009) and at 60 days (OR=3.8; p=0.004). Conclusions: GEMA-Na outperformed MELD-Na and MELD 3.0 to predict mortality in a context of waiting list shortening and it could obviate gender-disparities for accessing LT.">

  
  <link rel="alternate" hreflang="en" href="https://dguijo.com/publication/rodriguezperalvarez-2023-ilts/">
  
  <link rel="alternate" hreflang="spanish" href="https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/">

  


  
  
  
  <meta name="theme-color" content="hsl(339, 90%, 68%)">
  

  
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.0-1/css/all.min.css" integrity="sha256-4w9DunooKSr3MFXHXWyFER38WmPdm361bQS/2KUWZbU=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css" integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/github.min.css" crossorigin="anonymous" title="hl-light" disabled>
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark">
        
      
    

    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.5.1/leaflet.css" integrity="sha256-SHMGCYmST46SoyGgo4YR/9AlK1vf3ff84Aq9yK4hdqM=" crossorigin="anonymous">
    

    

    
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/lazysizes/5.1.2/lazysizes.min.js" integrity="sha256-Md1qLToewPeKjfAHU1zyPwOutccPAm5tahnaw7Osw0A=" crossorigin="anonymous" async></script>
      
    
      

      
      

      
    
      

      
      

      
    
      

      
      
        
      

      
    
      

      
      

      
    

  

  
  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato:400,700%7CRoboto%7CRoboto+Mono&display=swap">
  

  
  
  
  
  <link rel="stylesheet" href="/css/academic.css">

  





<script async src="https://www.googletagmanager.com/gtag/js?id=UA-271170290-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'UA-271170290-1', {});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  


  
  

  

  <link rel="manifest" href="/index.webmanifest">
  <link rel="icon" type="image/png" href="/images/icon_hue9ced1b224c29d79395b4f0742b6e11d_19396_32x32_fill_lanczos_center_3.png">
  <link rel="apple-touch-icon" type="image/png" href="/images/icon_hue9ced1b224c29d79395b4f0742b6e11d_19396_192x192_fill_lanczos_center_3.png">

  <link rel="canonical" href="https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/">

  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="David Guijo-Rubio">
  <meta property="og:url" content="https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/">
  <meta property="og:title" content="Performance of the gender-equity model for liver allocation (GEMA-Na) within the first 30 and 60 days of listing | David Guijo-Rubio">
  <meta property="og:description" content="Background: Models for liver transplant (LT) allocation have been trained to predict mortality or delisting for sickness at 90 days. Their performance in a context of waiting list shortening is uncertain. Methods: Retrospective study of two cohorts of patients enlisted for LT in the UK (2010-2020) and Australia (1997-2020). Mortality or delisting for sickness within the first 30 and 60 days was evaluated. Harrell’s c statistics (Hc) were used to assess discrimination. Results: In all, 7,133 patients from the UK (33% women) and 1,638 patients from Australia (26.4% women) were included. Mortality or delisting for sickness at 30 and 60 days were 2.6% and 4.5% in the UK, and 2.7% and 4.6% in Australia. In the UK at 30 days, GEMA-Na obtained the highest discrimination (Hc=0.818; 95%CI 0.783-0.853), followed by MELD-Na (Hc=0.796; 95%CI 0.759-0.834; p=0.004), and MELD 3.0 (Hc=0.782; 95%CI 0.743-0.821; p&lt;0.001). In Australia at 30 days, the most accurate forecasts came from GEMA-Na (Hc=0.832; 95%CI 0.770-0.894), followed by MELD 3.0 (Hc=0.805; 95%CI 0.737-0.872; p=0.030), and MELD-Na (Hc=0.789; 95%CI 0.717-0.861; p=0.018). The discrimination benefit of GEMA-Na at 30 days was more pronounced in women: Hc=0.824 (95%CI 0.767-0.822) in the UK, and Hc=0.856 (95%CI 0.768-0.944) in Australia. Results were similar at 60 days. Differential prioritization at 30 days occurred in 15% of patients when comparing GEMA-Na vs MELD-Na, and in 15.3% of patients when comparing GEMA-Na vs MELD 3.0. Patients differently prioritized by GEMA-Na over MELD-Na had higher risk of the outcome at 30 days (OR=2.5; p=0.043) and at 60 days (OR=4.2; p=0.005). Patients differently prioritized by GEMA-Na over MELD 3.0 had increased likelihood of the outcome at 30 days (OR=7.3; p=0.009) and at 60 days (OR=3.8; p=0.004). Conclusions: GEMA-Na outperformed MELD-Na and MELD 3.0 to predict mortality in a context of waiting list shortening and it could obviate gender-disparities for accessing LT."><meta property="og:image" content="https://dguijo.com/images/icon_hue9ced1b224c29d79395b4f0742b6e11d_19396_512x512_fill_lanczos_center_3.png">
  <meta property="twitter:image" content="https://dguijo.com/images/icon_hue9ced1b224c29d79395b4f0742b6e11d_19396_512x512_fill_lanczos_center_3.png"><meta property="og:locale" content="spanish">
  
    
      <meta property="article:published_time" content="2023-12-30T08:09:21&#43;00:00">
    
    <meta property="article:modified_time" content="2023-12-30T09:09:21&#43;01:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/"
  },
  "headline": "Performance of the gender-equity model for liver allocation (GEMA-Na) within the first 30 and 60 days of listing",
  
  "datePublished": "2023-12-30T08:09:21Z",
  "dateModified": "2023-12-30T09:09:21+01:00",
  
  "author": {
    "@type": "Person",
    "name": "Manuel Luis Rodríguez-Perálvarez"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "David Guijo-Rubio",
    "logo": {
      "@type": "ImageObject",
      "url": "https://dguijo.com/images/icon_hue9ced1b224c29d79395b4f0742b6e11d_19396_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "Background: Models for liver transplant (LT) allocation have been trained to predict mortality or delisting for sickness at 90 days. Their performance in a context of waiting list shortening is uncertain. Methods: Retrospective study of two cohorts of patients enlisted for LT in the UK (2010-2020) and Australia (1997-2020). Mortality or delisting for sickness within the first 30 and 60 days was evaluated. Harrell’s c statistics (Hc) were used to assess discrimination. Results: In all, 7,133 patients from the UK (33% women) and 1,638 patients from Australia (26.4% women) were included. Mortality or delisting for sickness at 30 and 60 days were 2.6% and 4.5% in the UK, and 2.7% and 4.6% in Australia. In the UK at 30 days, GEMA-Na obtained the highest discrimination (Hc=0.818; 95%CI 0.783-0.853), followed by MELD-Na (Hc=0.796; 95%CI 0.759-0.834; p=0.004), and MELD 3.0 (Hc=0.782; 95%CI 0.743-0.821; p\u003c0.001). In Australia at 30 days, the most accurate forecasts came from GEMA-Na (Hc=0.832; 95%CI 0.770-0.894), followed by MELD 3.0 (Hc=0.805; 95%CI 0.737-0.872; p=0.030), and MELD-Na (Hc=0.789; 95%CI 0.717-0.861; p=0.018). The discrimination benefit of GEMA-Na at 30 days was more pronounced in women: Hc=0.824 (95%CI 0.767-0.822) in the UK, and Hc=0.856 (95%CI 0.768-0.944) in Australia. Results were similar at 60 days. Differential prioritization at 30 days occurred in 15% of patients when comparing GEMA-Na vs MELD-Na, and in 15.3% of patients when comparing GEMA-Na vs MELD 3.0. Patients differently prioritized by GEMA-Na over MELD-Na had higher risk of the outcome at 30 days (OR=2.5; p=0.043) and at 60 days (OR=4.2; p=0.005). Patients differently prioritized by GEMA-Na over MELD 3.0 had increased likelihood of the outcome at 30 days (OR=7.3; p=0.009) and at 60 days (OR=3.8; p=0.004). Conclusions: GEMA-Na outperformed MELD-Na and MELD 3.0 to predict mortality in a context of waiting list shortening and it could obviate gender-disparities for accessing LT."
}
</script>

  

  


  


  





  <title>Performance of the gender-equity model for liver allocation (GEMA-Na) within the first 30 and 60 days of listing | David Guijo-Rubio</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="dark">

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Buscar</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  







<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/">David Guijo-Rubio</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar" aria-expanded="false" aria-label="Barra de navegación">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/">David Guijo-Rubio</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-center" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#about"><span>Principal</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#experience"><span>Experiencia</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#publications"><span>Publicaciones</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#teaching"><span>Docencia</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/press"><span>Prensa</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#contact"><span>Contacto</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">
      

      

      
      <li class="nav-item dropdown i18n-dropdown">
        <a href="#" class="nav-link dropdown-toggle" data-toggle="dropdown" aria-haspopup="true">
          <i class="fas fa-globe mr-1" aria-hidden="true"></i><span class="d-none d-lg-inline">Español</span>
        </a>
        <div class="dropdown-menu">
          <div class="dropdown-item dropdown-item-active">
            <span>Español</span>
          </div>
          
          <a class="dropdown-item" href="https://dguijo.com/publication/rodriguezperalvarez-2023-ilts/">
            <span>English</span>
          </a>
          
        </div>
      </li>
      

    </ul>

  </div>
</nav>


  <div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Performance of the gender-equity model for liver allocation (GEMA-Na) within the first 30 and 60 days of listing</h1>
  <div class="article-metadata">
    <p style="font-size: 15px;">

  
  <span>Manuel Luis Rodríguez-Perálvarez</span>, <span>Antonio Manuel Gómez-Orellana</span>, <span>Avik Majumdar</span>, <span>Michael Bailey</span>, <span>Geoffrey W McCaughan</span>, <span>Paul Gow</span>, <span>Marta Guerrero</span>, <span>Rhiannon Taylor</span>, <span><b style="color:#ffffff">David Guijo-Rubio</b></span>, <span>César Hervás-Martínez</span>, <span>Emmanuel A Tsochatzis</span></p>
  </div>

  

  
    


<div class="article-metadata">

  
  <span class="article-date">
    
    
      
    
    May 2023
  </span>
  

  

  

  
  
  

  
  

</div>

    











  



<div class="btn-links mb-3">
  
  








  





<button type="button" class="btn btn-outline-primary my-1 mr-1 js-cite-modal"
        data-filename="/publication/rodriguezperalvarez-2023-ilts/cite.bib">
  Citar
</button>















</div>


  
</div>



  <div class="article-container">

    
    <h3>Resumen</h3>
    <p class="pub-abstract">Background: Models for liver transplant (LT) allocation have been trained to predict mortality or delisting for sickness at 90 days. Their performance in a context of waiting list shortening is uncertain. Methods: Retrospective study of two cohorts of patients enlisted for LT in the UK (2010-2020) and Australia (1997-2020). Mortality or delisting for sickness within the first 30 and 60 days was evaluated. Harrell’s c statistics (Hc) were used to assess discrimination. Results: In all, 7,133 patients from the UK (33% women) and 1,638 patients from Australia (26.4% women) were included. Mortality or delisting for sickness at 30 and 60 days were 2.6% and 4.5% in the UK, and 2.7% and 4.6% in Australia. In the UK at 30 days, GEMA-Na obtained the highest discrimination (Hc=0.818; 95%CI 0.783-0.853), followed by MELD-Na (Hc=0.796; 95%CI 0.759-0.834; p=0.004), and MELD 3.0 (Hc=0.782; 95%CI 0.743-0.821; p&lt;0.001). In Australia at 30 days, the most accurate forecasts came from GEMA-Na (Hc=0.832; 95%CI 0.770-0.894), followed by MELD 3.0 (Hc=0.805; 95%CI 0.737-0.872; p=0.030), and MELD-Na (Hc=0.789; 95%CI 0.717-0.861; p=0.018). The discrimination benefit of GEMA-Na at 30 days was more pronounced in women: Hc=0.824 (95%CI 0.767-0.822) in the UK, and Hc=0.856 (95%CI 0.768-0.944) in Australia. Results were similar at 60 days. Differential prioritization at 30 days occurred in 15% of patients when comparing GEMA-Na vs MELD-Na, and in 15.3% of patients when comparing GEMA-Na vs MELD 3.0. Patients differently prioritized by GEMA-Na over MELD-Na had higher risk of the outcome at 30 days (OR=2.5; p=0.043) and at 60 days (OR=4.2; p=0.005). Patients differently prioritized by GEMA-Na over MELD 3.0 had increased likelihood of the outcome at 30 days (OR=7.3; p=0.009) and at 60 days (OR=3.8; p=0.004). Conclusions: GEMA-Na outperformed MELD-Na and MELD 3.0 to predict mortality in a context of waiting list shortening and it could obviate gender-disparities for accessing LT.</p>

    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Tipo</div>
          <div class="col-12 col-md-9">
            
            
            <a href="/publication/#1">
              Artículo de conferencia

            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publicación</div>
          <div class="col-12 col-md-9"><em>2023 Joint International Congress of ILTS, ELITA and LICAGE</em></div>

        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    





<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/&amp;text=Performance%20of%20the%20gender-equity%20model%20for%20liver%20allocation%20%28GEMA-Na%29%20within%20the%20first%2030%20and%2060%20days%20of%20listing" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/&amp;t=Performance%20of%20the%20gender-equity%20model%20for%20liver%20allocation%20%28GEMA-Na%29%20within%20the%20first%2030%20and%2060%20days%20of%20listing" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Performance%20of%20the%20gender-equity%20model%20for%20liver%20allocation%20%28GEMA-Na%29%20within%20the%20first%2030%20and%2060%20days%20of%20listing&amp;body=https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/&amp;title=Performance%20of%20the%20gender-equity%20model%20for%20liver%20allocation%20%28GEMA-Na%29%20within%20the%20first%2030%20and%2060%20days%20of%20listing" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://web.whatsapp.com/send?text=Performance%20of%20the%20gender-equity%20model%20for%20liver%20allocation%20%28GEMA-Na%29%20within%20the%20first%2030%20and%2060%20days%20of%20listing%20https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://dguijo.es/publication/rodriguezperalvarez-2023-ilts/&amp;title=Performance%20of%20the%20gender-equity%20model%20for%20liver%20allocation%20%28GEMA-Na%29%20within%20the%20first%2030%20and%2060%20days%20of%20listing" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>












  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  
    
    





  


  










  
  



  </div>
</div>

      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js" integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/highlight.min.js" integrity="sha256-eOgo0OtLL4cdq7RdwRUiGKLX9XsIJ7nGhWEKbohmVAQ=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/languages/r.min.js"></script>
        
      

    

    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.5.1/leaflet.js" integrity="sha256-EErZamuLefUnbMBQbsEqu1USa+btR2oIlCpBJbyD4/g=" crossorigin="anonymous"></script>
    

    
    
    <script>const code_highlighting = true;</script>
    

    
    
    <script>const isSiteThemeDark = true;</script>
    

    

    
    

    

    
    

    
    

    
    

    
    

    
    
    
    
    
    
    
    
    
    
    
    
    <script src="/js/academic.min.8741d44cdc5fc49466a5835d1bbea364.js"></script>

    






  
  
  <div class="container">
    <footer class="site-footer">
  

  <p class="powered-by">
    
    © David Guijo-Rubio. 2024  
    
    
    

    
    <span class="float-right" aria-hidden="true">
      <a href="#" class="back-to-top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>



  </div>
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Citar</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copiar
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Descargar
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
